Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on NOVARTIS AG
04/12 TORRENT PHARMACEUTICALS : Pharma to buy certain generic drugs from Novartis
04/07 NOVARTIS : to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indi..
04/06 NOVARTIS : Cota Healthcare Announces Major Multi-Year Collaboration With Global ..
04/06 NOVARTIS : Patent Issued for Prostaglandin Conjugates and Derivatives for Treati..
04/06 NOVARTIS : Patent Issued for Process for Preparing N-(4-Cyclohexyl-3-Trifluorome..
04/06 NOVARTIS : Patent Issued for Remote Magnetic Driven Flow System (USPTO 9603742)
04/06 NOVARTIS : Researchers Submit Patent Application, "Yeast Display Systems", for A..
04/06 NOVARTIS : to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indi..
04/04 NOVARTIS : drug combination Tafinlar + Mekinist receives EU approval for BRAF V6..
04/04 Vectura confirms launch of Utibron in US
04/03 NOVARTIS : drug combination Tafinlar® + Mekinist® receives EU approval for BRAF ..
03/31 NOVARTIS AG (ADR) (NYSE : NVS)’ Leukemia Drug Allowed Priority Review By T..
03/30 NOVARTIS : DSM Sinochem Pharmaceuticals announces licensing agreement for intell..
03/30 NOVARTIS : Researchers Submit Patent Application, "Impact of Genetic Factors on ..
03/30 NOVARTIS : New analysis shows Novartis Entresto improves glycemic control in red..
03/30DJOXFORD BIOMEDICA : Hails U.S. Regulatory Boost for Leukemia Treatment
03/30 NOVARTIS : Ionis Pharmaceuticals Inc. Doesn`t Want to Sell Drugs
03/29 NOVARTIS : announces first CAR-T cell therapy BLA for pediatric and young adult ..
03/29 FDA, Mylan silence on generic Advair may be good news for GSK
03/28 NOVARTIS : The New Americares-Sandoz Partnership Provides Even More Access to Me..
03/27 NOVARTIS AG : Blog Coverage Novartis Licences its Immunosenescence Drugs to Pure..
03/27 NOVARTIS : appoints new UK managing director
03/26 NOVARTIS INDIA : Quarterly results - novartis india limited
03/26 NOVARTIS INDIA : Trailing twelve month results - novartis india limited
03/24 NOVARTIS : Global Haloperidol Market 2017 - Sandoz, Mylan, Teva, Fresenius Kabi
03/24 NOVARTIS : $11,970 Federal Contract Awarded to Alcon Laboratories
03/24 PURETECH HEALTH : Inks Deal With Novartis To Develop Ageing Disorder Therapies
03/23 NOVARTIS : Lupin receives FDA approval for generic TOBI inhalation solution
03/23 NOVARTIS : Global Alprazolam Market 2017 - Endo, Mylan, Sandoz, Actavis, Apotex
03/23 NOVARTIS : Kisqali® ribociclib, LEE011 receives FDA approval as first-line treat..
03/23 OTSUKA : Ribociclib (LEE011) Receives Regulatory Approval in U.S. as a First-Lin..
03/23 NOVARTIS : Serelaxin Setback Puts Focus On Entresto
03/23 NOVARTIS : Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multi..
03/22 Global Inhalation & Nasal Spray Generic Drugs Market- Teva, Allergan PLC, Cip..
03/22 NOVARTIS` : Cosentyx is first and only IL-17A inhibitor to potentially modify th..
03/22 NOVARTIS : provides update on Phase III study of RLX030 (serelaxin) in patients ..
03/22 NOVARTIS : Fda clears glenmark skin cream
03/21 IMS HEALTH : Glenmark gets tentative nod from USFDA for Fingolimod capsules
03/21 NOVARTIS : ' Cosentyx is first and only IL-17A inhibitor to potentially modify t..
03/20 NOVARTIS : New analysis shows Novartis Entresto improves glycemic control in red..
03/18 NOVARTIS : New analysis shows Novartis Entresto improves glycemic control in red..
03/18 NOVARTIS : New analysis shows Novartis Entresto improves glycemic control in red..
03/17 NOVARTIS : UNECE Celebrates 25 Years of Industrial Accidents Convention, its Con..
03/16 NOVARTIS : Patent Issued for Vitrectomy Probe with Adjustable Cutter Port Size (..
03/16 NOVARTIS : Patent Issued for Ophthalmic Surgical Microscope with Adaptive Optics..
03/16 NOVARTIS' : Cosentyx® shows almost all psoriasis patients rapidly regain skin cl..
03/16 NOVARTIS : Ex-Novartis employee cleared of advertisement exaggeration charge
03/15 NOVARTIS : Kisqali (ribociclib, LEE011) receives FDA approval as first-line trea..
03/14 NOVARTIS : Kisqali (ribociclib, LEE011) receives FDA approval as first-line trea..
03/14 NOVARTIS : Sandoz biosimilar adalimumab study shows equivalent efficacy
03/13 NOVARTIS : FDA OKs new Novartis drug for type of advanced breast cancer
03/13 NOVARTIS : Kisqali® (ribociclib, LEE011) receives FDA approval as first-line tre..
03/13 NOVARTIS : Sandoz announces winners of inaugural Healthcare Access Challenge (Sa..
03/11 NOVARTIS : $27.41 Million Federal Contract Awarded to Sandoz
03/10 NOVARTIS : Carlsbad's Genoptix sold to investor group
03/09 NOVARTIS : Patent Issued for Optical Structures with Nanostructre Features and M..
03/09 NOVARTIS : Patent Issued for Surgical Cassette with Compliant Clamping Zone (USP..
03/09 NOVARTIS : Patent Issued for Tracking System for Surgical Optical Coherence Tomo..
03/08 Compare and contrast - Trump's tweets vs private comments to CEOs
03/08 POSITIVE RESULTS FOR ABBVIE INC (NYS : ABBV) Humira Biosimilar Reported By Novar..
03/07 European shares slip as Trump tweet hits drugmakers
03/06 NOVARTIS : ' Cosentyx shows almost all psoriasis patients rapidly regain skin cl..
03/06 NOVARTIS : New data demonstrate Sandoz proposed biosimilar adalimumab has equiva..
03/03 NOVARTIS AG (ADR) (NYSE : NVS) Fined And Some Products To Be Temporarily Suspend..
03/02 NOVARTIS : Patent Issued for Colored Contact Lenses and Method of Making the Sam..
03/02 NOVARTIS : Patent Issued for Compounds and Compositions as Kinase Inhibitors (US..
03/02 NOVARTIS : Patent Issued for Sub-Micron Alignment of a Monitoring Fiber for Opti..
03/02 NOVARTIS : Patent Issued for Intraocular Pressure Sensing System for Posterior S..
03/02DJNOVARTIS : Fined by South Korea Over Alleged Kickbacks
03/02 NOVARTIS : South Korea fines Novartis over kickbacks, suspends sales of some dru..
03/02 NOVARTIS : South Korea fines Novartis over kickbacks, suspends sales of some dru..
03/02 LUPIN : Launches solution for skin inflammation
03/02 NOVARTIS AG : ex-dividend day for annual dividend
02/28 EXCLUSIVE : Merus Labs hires Rothschild to explore options - sources
02/28 NOVARTIS : shareholders approve all resolutions proposed by Board of Directors a..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2017 48 338 M
EBIT 2017 11 983 M
Net income 2017 7 480 M
Debt 2017 14 035 M
Yield 2017 3,47%
P/E ratio 2017 24,81
P/E ratio 2018 21,99
EV / Sales 2017 4,71x
EV / Sales 2018 4,51x
Capitalization 213 719 M
More Financials
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 31
Average target price 80,0 $
Spread / Average Target -1,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Joseph Jimenez Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Kirsch Chief Financial Officer
Vasant Narasimhan Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG6.28%213 719
JOHNSON & JOHNSON10.23%342 817
ROCHE HOLDING LTD.14.79%237 610
PFIZER INC.-1.11%191 279
MERCK & CO., INC.8.78%175 160
SANOFI14.93%124 306
More Results